- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 22 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.16: 3 residues within 4Å:- Chain A: Y.3, N.5, N.36
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: T.99, N.100
Ligand excluded by PLIPNAG.18: 4 residues within 4Å:- Chain A: N.139, N.140, C.141, T.142
Ligand excluded by PLIPNAG.19: 6 residues within 4Å:- Chain A: N.171, G.174, I.208, N.209
- Chain C: K.437, E.440
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.255, E.256, N.257
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.306, P.554, Q.555
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: D.314, N.318, V.342, L.346
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.684
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: Y.3, N.36
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain B: N.97, T.99, N.100
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: E.107, N.139, N.140
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: N.209, T.211
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: N.255, N.257
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.306, Q.555
Ligand excluded by PLIPNAG.30: 6 residues within 4Å:- Chain B: D.314, N.318, V.342, L.343, L.346, F.349
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.684
- Chain C: Y.771
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain C: Y.3, N.36
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain C: N.97, T.99, V.102
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain C: E.107, N.139, N.140
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain C: T.83, N.209, T.211
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain C: N.255, E.256, N.257
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: Y.771
- Chain C: N.684
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Das, H. et al., SARS-CoV-2 omicron Spike (RBD) in complex with CAB-A17 antibody. To Be Published
- Release Date
- 2024-05-22
- Peptides
- Spike glycoprotein: ABC
CAB-A17 antibody (LC): DF
CAB-A17 antibody (HC): EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
EF
LE
FG
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 22 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Das, H. et al., SARS-CoV-2 omicron Spike (RBD) in complex with CAB-A17 antibody. To Be Published
- Release Date
- 2024-05-22
- Peptides
- Spike glycoprotein: ABC
CAB-A17 antibody (LC): DF
CAB-A17 antibody (HC): EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
EF
LE
FG
R